drugset / Trial / NCT00158756

Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants

NCT00158756

Phase 3 Completed 308 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

To compare the two formulations of GSK Biologicals' DTPw-HBV vaccine to concomitant administration of CSL's DTPw vaccine and GSK Biologicals' HBV with respect to the antibody response to the diphtheria antigen after a three-dose primary vaccination course.

Timeline

Start
2005-09-12
Primary completion
2006-11-01
Completion
2006-11-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Engerix-B Vaccine Intramuscular
Subject Rotarix Vaccine Oral
Comparator Triple Antigen™ Vaccine Intramuscular
Subject Tritanrix-HepB Vaccine Intramuscular
Comparator Zilbrix™ Vaccine Intramuscular